المؤلفون: Наумов , В. О., Білоконь , А. І.

المصدر: Ukrainian Journal of Civil Engineering and Architecture; No. 6 (024) (2024): Ukrainian Journal of Civil Engineering and Architecture; 109-122 ; Украинский журнал строительства и архитектуры; № 6 (024) (2024): Український журнал будівництва та архітектури; 109-122 ; Український журнал будівництва та архітектури; № 6 (024) (2024): Український журнал будівництва та архітектури; 109-122 ; 2710-0375 ; 2710-0367

مصطلحات موضوعية: демонтажні роботи, промислові об'єкти, ракети, руйнування, екскаватори з подовженою стрілою, технологічні рішення, безпека, цифрові технології, автоматизація, demolition works, industrial facilities, missiles, destruction, long-reach excavators, technological solutions, safety, digital technologies, automation

وصف الملف: application/pdf

Relation: http://uajcea.pgasa.dp.ua/article/view/319260/309644; http://uajcea.pgasa.dp.ua/article/view/319260

الاتاحة: http://uajcea.pgasa.dp.ua/article/view/319260
https://doi.org/10.30838/UJCEA.2312.27124.109.1118

المؤلفون: Наумов , В. О., Проценко , Д. О.

المصدر: Ukrainian Journal of Civil Engineering and Architecture; No. 2 (020) (2024): Ukrainian Journal of Civil Engineering and Architecture; 57-63 ; Украинский журнал строительства и архитектуры; № 2 (020) (2024): Український журнал будівництва та архітектури; 57-63 ; Український журнал будівництва та архітектури; № 2 (020) (2024): Український журнал будівництва та архітектури; 57-63 ; 2710-0375 ; 2710-0367

مصطلحات موضوعية: будівля, споруда, метод, спосіб, зруйновані вибухом, пошкоджені, динамічні навантаження, building, method, way, destroyed, explosion, damaged, dynamic loads

وصف الملف: application/pdf

Relation: http://uajcea.pgasa.dp.ua/article/view/305436/297048; http://uajcea.pgasa.dp.ua/article/view/305436

الاتاحة: http://uajcea.pgasa.dp.ua/article/view/305436
https://doi.org/10.30838/J.BPSACEA.2312.260324.57.1043

المؤلفون: Наумов, В. П. ((Владимир Павлович))

جغرافية الموضوع: Soviet Union -- History -- Historiography -- Revolution, 1917-1921

المؤلفون: Зимин, С. П., Тиванов, М. С., Колесников, Н. Н., Амиров, И. И., Мазалецкий, Л. А., Наумов, В. В., Ляшенко, Л. С., Королик, О. В.

مصطلحات موضوعية: ЭБ БГУ::ЕСТЕСТВЕННЫЕ И ТОЧНЫЕ НАУКИ::Физика

Relation: Взаимодействие излучений с твердым телом : материалы 15-й Междунар. конф., Минск, Беларусь, 26-29 сент. 2023 г. / Белорус, гос. ун-т; редкол.: В. В. Углов (гл. ред.) [и др.]. – Минск : БГУ, 2023. – С. 388-391.; 2663-9939 (Print); 2706-9060 (Online); https://elib.bsu.by/handle/123456789/304223

الاتاحة: https://elib.bsu.by/handle/123456789/304223

المؤلفون: Ахмедова, Н. Р., Валл, Е. В., Наумов, В. А.

مصطلحات موضوعية: ЭБ БГУ::ЕСТЕСТВЕННЫЕ И ТОЧНЫЕ НАУКИ::География, ЭБ БГУ::ЕСТЕСТВЕННЫЕ И ТОЧНЫЕ НАУКИ::Геодезия. Картография

Relation: Актуальные вопросы устойчивого природопользования: научно-методическое обеспечение и практическое решение : материалы междунар. науч.-практич. конференции, посвященной 60-летию НИЛ экологии ландшафтов факультета географии и геоинформатики БГУ, Минск, 9–11 ноября 2022 г. / БГУ, Фак. географии и геоинформатики; [редкол.: Д. С. Воробьёв (отв. ред.) и др.]. – Минск : БГУ, 2022. – С. 38-42.; https://elib.bsu.by/handle/123456789/291758; № 012309122022, Деп. в БГУ 09.12.2022

الاتاحة: https://elib.bsu.by/handle/123456789/291758

المؤلفون: БІЛОКОНЬ, А. І., НЕСЕВРЯ, П. І., НАУМОВ, В. О.

المصدر: Ukrainian Journal of Civil Engineering and Architecture; No. 3 (2022); 15-26 ; Украинский журнал строительства и архитектуры; № 3 (2022); 15-26 ; Український журнал будівництва та архітектури; № 3 (2022); 15-26 ; 2710-0375 ; 2710-0367

مصطلحات موضوعية: знесення будівель та споруд, демонтаж, основні технічні рішення, ключові фактори, що визначають ухвалення технічних рішень, demolition of buildings and structures, dismantling, basic technical solutions, key factors determining technical decision-making

وصف الملف: application/pdf

Relation: http://uajcea.pgasa.dp.ua/article/view/264058/260258; http://uajcea.pgasa.dp.ua/article/view/264058

الاتاحة: http://uajcea.pgasa.dp.ua/article/view/264058
https://doi.org/10.30838/J.BPSACEA.2312.050722.15.860

المؤلفون: СОКОЛОВ , І. А., НЕСЕВРЯ, П. І., НАУМОВ, В. О.

المصدر: Ukrainian Journal of Civil Engineering and Architecture; No. 2 (2022); 55-61 ; Украинский журнал строительства и архитектуры; № 2 (2022); 55-61 ; Український журнал будівництва та архітектури; № 2 (2022); 55-61 ; 2710-0375 ; 2710-0367

مصطلحات موضوعية: disassembly stages, problems with disassembly works, buildings and structures, demolition, disassembly algorithms, етапи демонтажу, проблеми під час виконання демонтажних робіт, будівлі та споруди, знесення, алгоритми демонтажу

وصف الملف: application/pdf

Relation: http://uajcea.pgasa.dp.ua/article/view/261164/257624; http://uajcea.pgasa.dp.ua/article/view/261164

الاتاحة: http://uajcea.pgasa.dp.ua/article/view/261164
https://doi.org/10.30838/J.BPSACEA.2312.260422.55.851

المؤلفون: БІЛОКОНЬ, А. І., НЕСЕВРЯ, П. І., НАУМОВ, В. О.

المصدر: Ukrainian Journal of Civil Engineering and Architecture; No. 1 (2022); 21-30 ; Украинский журнал строительства и архитектуры; № 1 (2022); 21-30 ; Український журнал будівництва та архітектури; № 1 (2022); 21-30 ; 2710-0375 ; 2710-0367

مصطلحات موضوعية: design of dismantling and demolition of buildings and structures, the main design decisions on the method of conducting work, проектування демонтажу та зносу будівель та споруд, основні проектні рішення щодо способу ведення робіт

وصف الملف: application/pdf

Relation: http://uajcea.pgasa.dp.ua/article/view/257571/254392; http://uajcea.pgasa.dp.ua/article/view/257571

الاتاحة: http://uajcea.pgasa.dp.ua/article/view/257571
https://doi.org/10.30838/J.BPSACEA.2312.220222.21.829

المؤلفون: Наумов, В. В., Федорова, С. В., Тельманова, Е. Д.

مصطلحات موضوعية: ЭКОНОМИКА ЭЛЕКТРОЭНЕРГЕТИКИ, ЭНЕРГОСБЕРЕЖЕНИЕ В ОБРАЗОВАНИИ, АНАЛОГОВЫЕ РЕГУЛЯТОРЫ, ЛАБОРАТОРНЫЕ ПРАКТИКУМЫ, ТАБЛИЧНЫЙ ПРОЦЕССОР MS EXCEL, УСТРОЙСТВА ОБЕЗВОЖИВАНИЯ, ЛИНЕЙНЫЕ ИНДУКТОРЫ, АСИНХРОННЫЕ ЭЛЕКТРОПРИВОДЫ, НОМОГРАММЫ, РЕГИСТРАТОРЫ ПЕРЕХОДНЫХ ПРОЦЕССОВ, ПРОГНОЗИРОВАНИЕ ЭЛЕКТРОПОТРЕБЛЕНИЯ, ЭНЕРГОЭФФЕКТИВНОЕ ОСВЕЩЕНИЕ, СРОК СЛУЖБЫ ТРАСФОРМАТОРА, ПЕРЕГРУЗКА ТРАСФОРМАТОРОВ, ПРЕОБРАЗОВАНИЕ ЭНЕРГИИ, ПЕРЕДАЧА ЭЛЕКТРИЧЕСКОЙ ЭНЕРГИИ, ОГРАНИЧЕНИЕ НАГРУЗКИ ТРАНСФОРМАТОРОВ, АВАРИЙНЫЕ РЕЖИМЫ РАБОТЫ ТРАНСФОРМАТОРОВ, ПОТЕРИ ЭЛЕКТРИЧЕСКОЙ ЭНЕРГИИ, ТЕРМОМАЙЗЕРЫ, ПРЕОБРАЗОВАТЕЛИ ЧАСТОТЫ, ФИЛЬТРО-КОМПЕНСИРУЮЩИЕ УСТРОЙСТВА, ПОДЪЕМНО-ТРАНСПОРТНОЕ ОБОРУДОВАНИЕ, ЖИЗНЕННЫЙ ЦИКЛ ОРГАНИЗАЦИИ, ИЗОЛЯЦИОННЫЕ МАТЕРИАЛЫ, ЭЛЕКТРОЭНЕРГЕТИКА РОССИИ, ЭНЕРГЕТИЧЕСКИЕ ПРЕДПРИЯТИЯ, ТЕХНИЧЕСКИЕ СРЕДСТВА АВТОМАТИЗАЦИИ, ДИВИДЕНДНАЯ ПОЛИТИКА, СИСТЕМЫ ПОСТОЯННОГО ТОКА

وصف الملف: application/pdf

Relation: Энергетика, электропривод, энергосбережение и экономика предприятий, организаций, учреждений : материалы межвузовской региональной научно-практической конференции студентов. — Екатеринбург, 2009; Наумов, В. В. Мировая система передачи электроэнергии Николы Тесла / В. В. Наумов, С. В. Федорова, Е. Д. Тельманова // Энергетика, электропривод, энергосбережение и экономика предприятий: вчера, сегодня, завтра : материалы межвузовской региональной научно-практической конференции студентов, 27 апреля 2009 г., г. Екатеринбург / Рос. гос. проф.-пед. ун-т. - Екатеринбург : РГППУ, 2009. - С. 90-94.; https://elar.rsvpu.ru/handle/123456789/36587

الاتاحة: https://elar.rsvpu.ru/handle/123456789/36587

المؤلفون: Наумов, В. К.

المساهمون: Боровик, Н. Э., науч. рук.

مصطلحات موضوعية: Белорусская республиканская пионерская организация, детские организации, общественные организации, октябрята, пионеры, Беларусь

وصف الملف: application/pdf

Relation: Наумов, В. К. Организация деятельности "октябрят" как этап включения молодёжи в работу общественных объединений Республики Беларусь / Наумов В. К.; науч. рук. Боровик Н. Э. // Молодость. Интеллект. Инициатива : материалы XII Международной научно-практической конференции студентов и магистрантов, Витебск, 26 апреля 2024 года : в 2 т. – Витебск : ВГУ имени П. М. Машерова, 2024. – Т. 2. – С. 180-182. – Библиогр.: с. 182 (4 назв.).; 55dd062eb8e006da5582b824b6c250ee; https://rep.vsu.by/handle/123456789/42866

الاتاحة: https://rep.vsu.by/handle/123456789/42866

المؤلفون: Батурский, М. О., Семенюк, В. П., науч. рук., Акинтинова, Е. В., науч. рук., Боровик, Н. Э., науч. рук., Наумов, В. К., науч. рук.

مصطلحات موضوعية: экскурсионные маршруты, экскурсии, историческая память, подвиги, Великая Отечественная война, памятники героям войны, мемориальные места, патриотические акции

وصف الملف: application/pdf

Relation: Батурский, М. О. Экскурсионный маршрут "Маршрут памяти, маршрут Победы" / Батурский М. О.; науч. рук. Семенюк В. П., Акинтинова Е. В., Боровик Н. Э., Наумов В. К. // Старт в науку : материалы VIII Международной научно-практической конференции обучающихся и студентов, Орша, 23 мая 2024 г. – Витебск : ВГУ имени П. М. Машерова, 2024. – С. 326-327.; fb1a0a375b0db79c340441af313ea100; https://rep.vsu.by/handle/123456789/43755

الاتاحة: https://rep.vsu.by/handle/123456789/43755

المؤلفون: Наумов, В. В., Афонин, П. В.

مصطلحات موضوعية: геотекстиль, нетканый геотекстиль, поверхностная плотность геотекстиля, технологические параметры

وصف الملف: application/pdf

Relation: Наумов, В. В. Поверхностная плотность нетканого геотекстиля как устаревший технологический параметр / В. В. Наумов, П. В. Афонин // Лесная инженерия, материаловедение и дизайн : материалы 88-й научно-технической конференции профессорско-преподавательского состава, научных сотрудников и аспирантов, Минск, 24 января–16 февраля 2024 г. – Минск : БГТУ, 2024. – С. 129-130.; https://elib.belstu.by/handle/123456789/64516; 677.076.49

الاتاحة: https://elib.belstu.by/handle/123456789/64516

المؤلفون: I. Sarvilina V., O. Gromova A., A. Naumov V., И. Сарвилина В., О. Громова А., А. Наумов В.

المساهمون: Publication of this article has been supported by Sotex PharmFirma., Статья опубликована при поддержке компании ЗАО «ФармФирма «Сотекс».

المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 13, No 5 (2021); 109-115 ; Неврология, нейропсихиатрия, психосоматика; Vol 13, No 5 (2021); 109-115 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2021-5

مصطلحات موضوعية: COVID-19, neurological symptoms, redox status, chondroitin sulfate, неврологические симптомы, редокс-статус, хондроитина сульфат

وصف الملف: application/pdf

Relation: https://nnp.ima-press.net/nnp/article/view/1674/1319; Доступно по ссылке: https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019; Yu C. Study Probes the ‘Long Haul’ effects of COVID-19. Johns Hopkins University Hub. 2021. Available from: https://hub.jhu.edu/2021/03/22/long-covid-long-haulers/ (accessed 25.04.2021).; Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network – United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-8. doi:10.15585/mmwr.mm6930e1; Jones JF, Ray CG, Minnich LL, et al. Evidence for active Epstein-Barr virus infection in patientswith persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med. 1985 Jan;102(1):1-7. doi:10.7326/0003-4819-102-1-7; Wray BB, Gaughf C, Chandler Jr FW, et al. Detection of Epstein-Barr virus and cytomegalovirus in patients with chronic fatigue. Ann Allergy. 1993 Sep;71(3):223-6.; Komaroff AL. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J Clin Virol. 2006 Dec;37 Suppl 1:S39-46. doi:10.1016/S1386-6532(06)70010-5; Fraternale A, Paoletti MF, Casabianca A, et al. GSH and analogs in antiviral therapy. Mol Aspects Med. Feb-Apr 2009;30(1-2):99-110. doi:10.1016/j.mam.2008.09.001. Epub 2008 Sep 27.; Camini FC, da Silva Caetano CC, Almeida LT, de Brito Magalhaes CL. Implications of oxidative stress on viral pathogenesis. Arch Virol. 2017 Apr;162(4):907-17. doi:10.1007/s00705-016-3187-y. Epub 2016 Dec 30.; Rank N, Michel C, Haertel C, et al. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. Crit Care Med. 2000 Dec;28(12):3799-807. doi:10.1097/00003246-200012000-00006; Bischoff SC. Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):733-40. doi:10.1097/MCO.0b013e32831394b8; Urata Y, Honma S, Goto S, et al. Melatonin induces gamma-glutamylcysteinesynthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radic Biol Med. 1999 Oct;27(7-8):838-47. doi:10.1016/s0891-5849(99)00131-8; Harris E, Schulzke SM, Patole SK. Pentoxifylline in preterm neonates: a systematic review. Paediatr Drugs. 2010 Oct 1;12(5):301-11. doi:10.2165/11532600-000000000-00000; Баринов АН, Мошхоева ЛС, Пархоменко ЕВ и др. Клинические проявления, патогенез и лечение отдаленных последствий поражения нервной системы при COVID-19. Медицинский алфавит. 2021;(3):14-22. doi:10.33667/2078-5631-2021-3-14-22; Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021 Aug 9;11(1):16144. doi:10.1038/s41598-021-95565-8; World Health Organization (1969). Manual of the International Statistical Classification of Diseases, Injuries, Causes of Death Based on the Recommendations of the Eighth Revision Conference (PDF). 2 (Eighth ed.). Geneva: WHO. p. 173. Available from: https://me-pedia.org/wiki/Epidemic_myalgic_encephalomyelitis (accessed 25.04.2021).; Davis HE, Assaf GS, McCorkell L, et al. Characterizing Long COVID in an international cohort: 7 months of symptoms and their impact. medRxiv. 2020;12.24.20248802. doi:10.1101/2020.12.24.20248802; Klopfenstein T, Kadiane-Oussou NJ, Toko L, et al. Features of anosmia in COVID-19. Med Mal Infect. 2020. doi:10.1016/j.medmal.2020.04.006 [Epub ahead of print].; Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington (DC): National Academies Press (US); 2015 Feb 10.; Nakatomi Y, Mizuno K, Ishii A, et al. Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an (1)(1)C-(R)-PK11195 PET study. J Nucl Med. 2014 Jun;55(6):945-50. doi:10.2967/jnumed.113.131045. Epub 2014 Mar 24.; Tak LM, Cleare AJ, Ormel J, et al. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol Psychol. 2011 May;87(2):183-94. doi:10.1016/j.biopsycho.2011.02.002. Epub 2011 Feb 18.; Van Campen CLMC, Rowe PC, Visser FC. Cerebral blood flow is reduced in severe myalgic encephalomyelitis/chronic fatigue syndrome patients during mild orthostatic stress testing: an exploratory study at 20 degrees of head-up tilt testing. Healthcare (Basel). 2020 Jun 13;8(2):169. doi:10.3390/healthcare8020169; Baraniuk JN, Casado B, Maibach H, et al. A chronic fatigue syndrome – related proteome in human cerebrospinal fluid. BMC Neurol. 2005 Dec 1;5:22. doi:10.1186/1471-2377-5-22; Sotzny F, Blanco J, Capelli E, et al. Myalgic encephalomyelitis/chronic fatigue syndrome evidence for an autoimmune disease. Autoimmun Rev. 2018 Jun;17(6):601-9. doi:10.1016/j.autrev.2018.01.009. Epub 2018 Apr 7.; Jones DE, Hollingsworth KG, Jakovljevic DG, et al. Loss of capacity to recover from acidosis n repeat exercise in chronic fatigue syndrome: a casecontrol study. Eur J Clin Investig. 2012 Feb;42(2):186-94. doi:10.1111/j.1365-2362.2011.02567.x. Epub 2011 Jul 12.; Solomon IH, Normandin E, Bhattacharyya S, et al. Neuropathological features of Covid-19. N Engl J Med. 2020 Sep 3;383(10):989-92. doi:10.1056/NEJMc2019373. Epub 2020 Jun 12.; Lersy F, Benotmane I, Helms J, et al. Cerebrospinal fluid features in COVID-19 patients with neurologic manifestations: correlation with brain MRI findings in 58 patients. J Infect Dis. 2021 Feb 24;223(4):600-9. doi:10.1093/infdis/jiaa745; Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020 Apr 1;11(7):995-8. doi:10.1021/acschemneuro.0c00122. Epub 2020 Mar 13.; Lapina CMR, Peschanski D, Mesmoudi S. The potential genetic network of human brain SARS-CoV-2 infection. bioRxiv. 2020.; Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020 Jun;92(6):552-5. doi:10.1002/jmv.25728. Epub 2020 Mar 11.; Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J Gastroenterol Hepatol. 2020 May;35(5):744-8. doi:10.1111/jgh.15047. Epub 2020 Apr 19.; Glass CK, Saijo K, Winner B, et al. Mechanisms Underlying Inflammation in Neurodegeneration. Cell. 2010 Mar 19;140(6):918-34. doi:10.1016/j.cell.2010.02.016; Takeuchi H. Roles of glial cells in neuroinflammation and neurodegeneration. Clin Exp Neuroimmunol. 2013;4:2-16. doi:10.1111/cen3.12059; Gallagher PG. Hemolytic anemias: red blood cell membrane and metabolic defects. In: Goldman L, Schafer AI, editors. Goldman-Cecil Medicine. 25 th ed. Philadelphia, PA: Elsevier Saunders; 2016.; Janz DR, Bastarache JA, Sills G, et al. Association between haptoglobin, hemopexin and mortality in adults with sepsis. Crit Care. 2013 Nov 14;17(6):R272. doi:10.1186/cc13108; Curry FE. Layer upon layer: The functional consequences of disrupting the glycocalyxendothelial barrier in vivo and in vitro. Cardiovasc Res. 2017 May 1;113(6):559-61. doi:10.1093/cvr/cvx044; Yamano E, Sugimoto M, Hirayama A, et al. Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. Sci Rep. 2016 Oct 11;6:34990. doi:10.1038/srep34990; Armstrong CW, McGregor NR, Lewis DP, et al. Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients. Metabolomics. 2015;11:1626-39. doi:10.1007/s11306-015-0816-5; Naviaux RK. Metabolic features and regulation of the healing cycle – a new model for chronic disease pathogenesis and treatment. Mitochondrion. 2019 May;46:278-97. doi:10.1016/j.mito.2018.08.001. Epub 2018 Aug 9.; Maes M, Kubera M, Uytterhoeven M, et al. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Med Sci Monit. 2011 Apr;17(4):SC11-5. doi:10.12659/msm.881699; Robinson M, Gray SR, Watson MS, et al. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome. Scand J Med. Sci Sports. 2010 Apr;20(2):282-90. doi:10.1111/j.16000838.2009.00895.x. Epub 2009 Apr 13.; Miwa K, Fujita M. Increased oxidative stress suggested by low serum vitamin E concentrations in patients with chronic fatigue syndrome. Int J Cardiol. 2009 Aug 14;136(2):238-9. doi:10.1016/j.ijcard.2008.04.051. Epub 2008 Aug 6.; Fenouillet E, Vigouroux A, Steinberg JG, et al. Association of biomarkers with healthrelated quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients. J Transl Med. 2016 Aug 31;14(1):251. doi:10.1186/s12967-016-1010-x; Suarez A, Guillamo E, Roig T, et al. Nitric oxide metabolite production during exercise in chronic fatigue syndrome: a case-control study. J Women’s Health (Larchmt). 2010 Jun;19(6):1073-7. doi:10.1089/jwh.2008.1255; Paula BD, Lemled MD, Komaroffe AL, Solomon H. Snyder Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. PNAS. 2021 Aug 24;118(34):e2024358118. doi:10.1073/pnas.2024358118; Yang X, Zhang Y, Xu H, et al. Neuroprotection of coenzyme Q10 in neurodegenerative diseases. Curr Top Med Chem. 2016;16(8):858-66. doi:10.2174/1568026615666150827095252; Kappert K, Jahic A, Tauber R. Assessment of serum ferritin as a biomarker in COVID-19: Bystander or participant? Insights by comparison with other infectious and non-infectious diseases. Biomarkers. 2020 Dec;25(8):616-25. doi:10.1080/1354750X.2020.1797880. Epub 2020 Nov 24.; Shen B, Yi X, Sun Y, et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell. 2020 Jul 9;182(1):59-72.e15. doi:10.1016/j.cell.2020.05.032. Epub 2020 May 28.; Manuel y Keenoy B, Moorkens G, Vertommen J, De Leeuw I. Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. Life Sci. 2001 Mar 16;68(17):2037-49. doi:10.1016/s0024-3205(01)01001-3; Song JW, Lam SM, Fan X, et al. Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 2020 Aug 4;32(2):188-202.e5. doi:10.1016/j.cmet.2020.06.016. Epub 2020 Jun 24.; Ponti G, Ruini C, Tomasi A. Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19. Med Hypotheses. 2020 Oct;143:109859. doi:10.1016/j.mehy.2020.109859. Epub 2020 May 21.; Regland B, Andersson M, Abrahamsson L, et al. Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scand J Rheumatol. 1997;26(4):301-7. doi:10.3109/03009749709105320; Abouhashem AS, Singh K, Azzazy HME, Sen CK. Is low alveolar type II cell SOD3 in the lungs of elderly linked to the observed severity of COVID-19? Antioxid Redox Signal. 2020 Jul 10;33(2):59-65. doi:10.1089/ars.2020.8111. Epub 2020 May 8.; Kurup RK, Kurup PA. Hypothalamic digoxin, cerebral chemical dominance and myalgic encephalomyelitis. Int J Neurosci. 2003 May;113(5):683-701. doi:10.1080/00207450390200026; Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-9. doi:10.1001/jama.2020.1585; Brenu EW, Huth TK, Hardcastle SL, et al. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis. Int Immunol. 2014 Apr;26(4):233-42. doi:10.1093/intimm/dxt068. Epub 2013 Dec 16.; Karki R, Sharma BR, Tuladhar S, et al. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021 Jan 7;184(1):149-168.e17. doi:10.1016/j.cell.2020.11.025. Epub 2020 Nov 19.; Lemle MD. Hypothesis: Chronic fatigue syndrome is caused by dysregulation of hydrogen sulfide metabolism. Med Hypotheses. 2009 Jan;72(1):108-9. doi:10.1016/j.mehy.2008.08.003. Epub 2008 Sep 16.; Renieris G, Katrini K, Damoulari C, et al. Serum hydrogen sulfide and outcome association in pneumonia by the SARS-CoV-2 coronavirus. Shock. 2020 Nov;54(5):633-7. doi:10.1097/SHK.0000000000001562; Blackstone E, Morrison M, Roth M. B. H2S induces a suspended animation-like state in mice. Science. 2005 Apr 22;308(5721):518. doi:10.1126/science.1108581; Thomas T, Stefanoni D, Reisz JA, et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020 Jul 23;5(14):e140327. doi:10.1172/jci.insight.140327; Heer CD, Sanderson DJ, Voth LS, et al. Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity. J Biol Chem. 2020 Dec 25;295(52):17986-96. doi:10.1074/jbc.RA120.015138. Epub 2020 Oct 13.; Kennedy G, Spence VA, McLaren M, et al. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med. 2005 Sep 1;39(5):584-9. doi:10.1016/j.freeradbiomed.2005.04.020; Polonikov A. Endogenous deficiency of glutathione as the most likely cause of serious manifestations and death in COVID-19 patients. ACS Infect Dis. 2020 Jul 10;6(7):1558-62. doi:10.1021/acsinfecdis.0c00288. Epub 2020 May 28.; Rhodes JM, Subramanian S, Laird E, et al. Perspective: Vitamin D deficiency and COVID-19 severity – plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2, and thrombosis. J Intern Med. 2021 Jan;289(1):97-115. doi:10.1111/joim.13149. Epub 2020 Jul 22.; Aoki T, Miyakoshi H, Usuda Y, Herberman RB. Low NK syndrome and its relationship to chronic fatigue syndrome. Clin Immunol Immunopathol. 1993 Dec;69(3):253-65. doi:10.1006/clin.1993.1178; Zhang J, Taylor EW, Bennett K, et al. Association between regional selenium status and reported outcome of COVID-19 cases in China. Am J Clin Nutr. 2020 Jun 1;111(6):1297-9. doi:10.1093/ajcn/nqaa095; Chiscano-Camon L, Ruiz-Rodriguez JC, Ruiz-Sanmartin A, et al. Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome. Crit Care. 2020 Aug 26;24(1):522. doi:10.1186/s13054-020-03249-y; Kennedy G, Khan F, Hill A, et al. Biochemical and vascular aspects of pediatric chronic fatigue syndrome. Arch Pediatr Adolesc Med. 2010 Sep;164(9):817-23. doi:10.1001/archpediatrics.2010.157; Miwa K, Fujita M. Fluctuation of serum vitamin E (alpha-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome. Heart Vessels. 2010 Jul;25(4):319-23. doi:10.1007/s00380-009-1206-6. Epub 2010 Jul 31.; Erol SA, Tanacan A, Anuk AT, et al. Evaluation of maternal serum afamin and vitamin E levels in pregnant women with COVID-19 and its association with composite adverse perinatal outcomes. J Med Virol. 2021 Apr;93(4):2350-8. doi:10.1002/jmv.26725. Epub 2020 Dec 23.; Vecchiet J, Cipollone F, Falasca K, et al. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett. 2003 Jan 2;335(3):151-4. doi:10.1016/s0304-3940(02)01058-3; Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-4. doi:10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.; Rolls A, Avidan H, Cahalon L, et al. A disaccharide derived from chondroitin sulphate proteoglycan promotes central nervous system repair in rats and mice. Eur J Neurosci. 2004 Oct;20(8):1973-83. doi:10.1111/j.1460-9568.2004.03676.x; Rolls A, Cahalon L, Bakalash S, et al. A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration. FASEB J. 2006 Mar;20(3):547-9. doi:10.1096/fj.05-4540fje. Epub 2006 Jan 5.; Morawski M, Bruckner MK, Riederer P, et al. Perineuronal nets potentially protect against oxidative stress. Exp Neurol. 2004 Aug;188(2):309-15. doi:10.1016/j.expneurol.2004.04.017; Canas N, Valero T, Villarroya M, et al. Chondroitin sulfate protects SH-SY5Y cells from oxidative stress by inducing hemeoxygenase-1via phosphatidylinositol 3-kinase/Akt. J Pharmacol Exp Ther. 2007 Dec;323(3):946-53. doi:10.1124/jpet.107.123505. Epub 2007 Sep 20.; Sivasankaran R, Pei J, Wang KC, et al. PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration. Nat Neurosci. 2004 Mar;7(3):261-8. doi:10.1038/nn1193. Epub 2004 Feb 8.; Sato Y, Nakanishi K, Tokita Y, et al. A highly sulfated chondroitin sulfate preparation, CS-E, prevents excitatory aminoacidinduced neuronal cell death. J Neurochem. 2008 Mar;104(6):1565-76. doi:10.1111/j.1471-4159.2007.05107.x. Epub 2007 Nov 7.; Громова ОА, Торшин ИЮ, Семенов ВА и др. О неврологических ролях хондроитина сульфата и глюкозамина сульфата: систематический анализ. Неврология, нейропсихиатрия, психосоматика. 2019;11(3):137-43. https://doi.org/10.14412/2074-2711-2019-3-137-143; https://nnp.ima-press.net/nnp/article/view/1674

الاتاحة: https://nnp.ima-press.net/nnp/article/view/1674
https://doi.org/10.14412/2074-2711-2021-5-109-115

المؤلفون: A. Naumov V., T, Prokofieva V., O. Polunina S., L. Saroyants V., E. Polunina A., А. Наумов В., Т. Прокофьева В., О. Полунина С., Л. Сароянц В., Е. Полунина А.

المصدر: Medical Herald of the South of Russia; Том 12, № 4 (2021); 46-53 ; Медицинский вестник Юга России; Том 12, № 4 (2021); 46-53 ; 2618-7876 ; 2219-8075 ; 10.21886/2219-8075-2021-12-4

مصطلحات موضوعية: apoptosis, annexin V, heat shock proteins, HSP70, myocardial infarction, chronic obstructive pulmonary disease, апоптоз, аннексин V, белки теплового шока, белок теплового шока 70, инфаркт миокарда, хроническая обструктивная болезнь лёгких

وصف الملف: application/pdf

Relation: https://www.medicalherald.ru/jour/article/view/1430/855; https://www.medicalherald.ru/jour/article/downloadSuppFile/1430/521; https://www.medicalherald.ru/jour/article/downloadSuppFile/1430/522; https://www.medicalherald.ru/jour/article/downloadSuppFile/1430/523; https://www.medicalherald.ru/jour/article/downloadSuppFile/1430/524; Погосова Н.В., Соколова О.Ю., Юферова Ю.М., Осипова И.В., Рямзина И.Н. Первые результаты анализа российской части европейского регистра по кардиореабилитации (European cardiac rehabilitation database-eurocared) с участием 13 стран. Кардиология. 2015; 55(2):49-56.; Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018; 12:1753465817750524. DOI:10.1177/1753465817750524.; Goedemans L, Bax JJ, Delgado V. COPD and acute myocardial infarction. Eur Respir Rev. 2020; 29(156):190139. DOI:10.1183/16000617.0139-2019.; Kunisaki KM, Dransfield MT, Anderson JA, Brook RD, Calverley PMA, et al. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial. Am J Respir Crit Care Med. 2018; 198(1):51-57. DOI:10.1164/rccm.201711-2239OC.; Pizarro S, García-Lucio J, Peinado VI, Tura-Ceide O, Díez M, et al. Circulating progenitor cells and vascular dysfunction in chronic obstructive pulmonary disease. PLoS One. 2014; 9(8):e106163. DOI:10.1371/journal.pone.0106163. Erratum in: PLoS One. 2014; 9(12):e115566.; García-Lucio J, Peinado VI, de Jover L, Del Pozo R, Blanco I, et al. Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease. PLoS One. 2018; 13(4):e0195724. DOI:10.1371/journal.pone.0195724; Trinkmann F, Saur J, Borggrefe M, Akin I. Cardiovascular Comorbidities in Chronic Obstructive Pulmonary Disease (COPD)-Current Considerations for Clinical Practice. J Clin Med. 2019; 8(1):69. DOI:10.3390/jcm8010069.; Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agustí A. Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care. Am J Respir Crit Care Med. 2016; 194(11):1319-1336. DOI:10.1164/rccm.201604-0690SO.; Lee H, Shin SH, Gu S, Zhao D, Kang D, et al. Racial differences in comorbidity profile among patients with chronic obstructive pulmonary disease. BMC Med. 2018; 16(1):178. DOI:10.1186/s12916-018-1159-7.; Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol. 2000; 2(7):399-406. DOI:10.1038/35017029.; Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet. 2000; 356(9225):209- 12. DOI:10.1016/s0140-6736(00)02482-x.; Kupcho K, Shultz J, Hurst R, Hartnett J, Zhou W, et al. A realtime, bioluminescent annexin V assay for the assessment of apoptosis. Apoptosis. 2019; 24(1-2):184-197. DOI:10.1007/s10495-018-1502-7.; Mathangasinghe Y, Fauvet B, Jane SM, Goloubinoff P, Nillegoda NB. The Hsp70 chaperone system: distinct roles in erythrocyte formation and maintenance. Haematologica. 2021; 106(6):1519-1534. DOI:10.3324/haematol.2019.233056.; Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013; 187(7):728-35. DOI:10.1164/rccm.201209-1665OC.; Кузьмичев Б.Ю., Воронина Л.П., Тарасочкина Д.С., Полунина О.С., Прокофьева Т.В. и др. Гипергомоцистеинемия как фактор риска осложненного течения инфаркта миокарда на фоне хронической обструктивной болезни легких. Астраханский медицинский журнал. 2019; 14(3):79-87. eLIBRARY ID: 41550888; Васина Л.В., Луговая А.В., Петрищев Н.Н., Серебряная Н.Б. Патогенетическое значение изменения относительного содержания аннексин V+мононуклеаров и CD 59+-лимфоцитов периферической крови при остром коронарном синдроме. Медико-биологические и социальнопсихологические проблемы безопасности в чрезвычайных ситуациях. 2088;(1):74-80. eLIBRARY ID: 21139575; Chiong M, Wang ZV, Pedrozo Z, Cao DJ, Troncoso R, et al. Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis. 2011; 2(12):e244. DOI:10.1038/cddis.2011.130.; Masoudi FA, Ponirakis A, Yeh RW, Maddox TM, Beachy J, et al. Cardiovascular care facts: a report from the national cardiovascular data registry: 2011. J Am Coll Cardiol. 2013; 62(21):1931-1947. DOI:10.1016/j.jacc.2013.05.099.; Foo RS, Mani K, Kitsis RN. Death begets failure in the heart. J Clin Invest. 2005; 115(3):565-71. DOI:10.1172/JCI24569.; Shekhar A, Heeger P, Reutelingsperger C, Arbustini E, Narula N, et al. Targeted Imaging for Cell Death in Cardiovascular Disorders. JACC Cardiovasc Imaging. 2018; 11(3):476- 493. DOI:10.1016/j.jcmg.2017.11.018.; Osende Olea JI. Anexina V en jóvenes con infarto de miocardio: nuevas respuestas traen nueva preguntas [Annexin V levels in young patients with acute myocardial infarction: new answers bring new questions]. Rev Esp Cardiol. 2002; 55(12):1223-5. (in Spanish). DOI:10.1016/s0300-8932(02)76792-4.; Wei YJ, Huang YX, Shen Y, Cui CJ, Zhang XL, et al. Proteomic analysis reveals significant elevation of heat shock protein 70 in patients with chronic heart failure due to arrhythmogenic right ventricular cardiomyopathy. Mol Cell Biochem. 2009; 332(1-2):103-11. DOI:10.1007/s11010-009-0179-1.; Patterson C, Cyr D. Welcome to the machine: a cardiologist’s introduction to protein folding and degradation. Circulation. 2002; 106(21):2741-6. DOI:10.1161/01.cir.0000041145.30519.6b.; https://www.medicalherald.ru/jour/article/view/1430

الاتاحة: https://www.medicalherald.ru/jour/article/view/1430
https://doi.org/10.21886/2219-8075-2021-12-4-46-53

المؤلفون: N. Khovasova O., A. Naumov V., O. Tkacheva N., Н. Ховасова О., А. Наумов В., О. Ткачева Н.

المصدر: Meditsinskiy sovet = Medical Council; № 12 (2021); 398-404 ; Медицинский Совет; № 12 (2021); 398-404 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: anemia, surgical treatment, perioperative period, perioperative anemia, iron deficiency anemia, functional iron deficiency, high-dose iron preparations, анемия, оперативное лечение, периоперационный период, периоперационная анемия, железодефицитная анемия, функциональный дефицит железа, высокодозные препараты железа

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/6376/5773; Поликарпов А.В., Александрова Г.А., Голубев Н.А., Тюрина Е.М., Огрызко Е.В., Магазейщикова Н.Г., Шелепова Е.А. Ресурсы и деятельность медицинских организаций здравоохранения. Основные показатели здравоохранения. М.; 2019. Ч. 6, 49 с. Режим доступа: https://minzdrav.gov.ru/ministry/61/22/stranitsa-979/statisticheskie-i-informatsionnyematerialy/statisticheskiy-sbornik-2018-god.; Fowler A.J., Abbott T.E.F., Prowle J., Pearse R.M. Age of patients undergoing surgery. Br J Surg. 2019;106(8):1012–1018. https://doi.org/10.1002/bjs.11148.; Hewitt J., McCormack C., Tay H.S., Greig M., Law J., Tay A. et al. Prevalence of multimorbidity and its association with outcomes in older emergency general surgical patients: an observational study. BMJ Open. 2016;6(3):e010126. https://doi.org/10.1136/bmjopen-2015-010126.; McRae P.J., Peel N.M., Walker P.J., de Looze J.W., Mudge A.M. Geriatric syndromes in individuals admitted to vascular and urology surgical units. J Am Geriatr Soc. 2014;62(6):1105–1109. https://doi.org/10.1111/jgs.12827.; Mohanty S., Rosenthal R.A., Russell M.M., Neuman M.D., Ko C.Y., Esnaola N.F. Optimal Perioperative Management of the Geriatric Patient: A Best Practices Guideline from the American College of Surgeons NSQIP and the American Geriatrics Society. J Am Coll Surg. 2016;222(5):930–947. https://doi.org/10.1016/j.jamcollsurg.2015.12.026.; Chueh H.W., Jung H.L., Shim Y.J., Choi H.S., Han J.Y. High anemia prevalence in Korean older adults, an advent healthcare problem: 2007– 2016 KNHANES. BMC Geriatr. 2020;20(1):509. https://doi.org/10.1186/s12877-020-01918-9.; McLean E., Cogswell M., Egli I., Wojdyla D., de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005. Public Health Nutr. 2009;12(4):444–454. https://doi.org/10.1017/S1368980008002401.; Shander A., Lobel G.P., Javidroozi M. Anesthesia for Patients with Anemia. Anesthesiol Clin. 2016;34(4):711–730. https://doi.org/10.1016/j.anclin.2016.06.007.; Bateman A.P., McArdle F., Walsh T.S. Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med. 2009;37(6):1906–1912. https://doi.org/10.1097/CCM.0b013e3181a000cf.; Koch C.G., Li L., Sun Z., Hixson E.D., Tang A.S., Phillips S.C. et al. From Bad to Worse: Anemia on Admission and Hospital-Acquired Anemia. J Patient Saf. 2017;13(4):211–216. https://doi.org/10.1097/PTS.0000000000000142.; Koch C.G., Li L., Sun Z., Hixson E.D., Tang A., Chagin K. et al. Magnitude of Anemia at Discharge Increases 30-Day Hospital Readmissions. J Patient Saf. 2017;13(4):202–206. https://doi.org/10.1097/PTS.0000000000000138.; Muñoz M., Laso-Morales M.J., Gómez-Ramírez S., Cadellas M., Núñez-Matas M.J., García-Erce J.A. Pre-operative haemoglobin levels and iron status in a large multicentre cohort of patients undergoing major elective surgery. Anaesthesia. 2017;72(7):826–834. https://doi.org/10.1111/anae.13840.; Gómez-Ramirez S., Jericó C., Muñoz M. Perioperative anemia: Prevalence, consequences and pathophysiology. Transfus Apher Sci. 2019;58(4): 369–374. https://doi.org/10.1016/j.transci.2019.06.011.; Padmanabhan H., Aktuerk D., Brookes M.J., Nevill A.M., Ng A., Cotton J., Luckraz H. Anemia in cardiac surgery: next target for mortality and morbidity improvement? Asian Cardiovasc Thorac Ann. 2016;24(1):12–17. https://doi.org/10.1177/0218492315618032.; Musallam K.M., Tamim H.M., Richards T., Spahn D.R., Rosendaal F.R., Habbal A. et al. Preoperative anaemia and postoperative outcomes in noncardiac surgery: a retrospective cohort study. Lancet. 2011;378(9800): 1396–1407. https://doi.org/10.1016/S0140-6736(11)61381-0.; Baron D.M., Hochrieser H., Posch M., Metnitz B., Rhodes A., Moreno R.P. et al. Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth. 2014;113(3):416–423. https://doi.org/10.1093/bja/aeu098.; Joshi S.S., George A., Manasa D., Savita H.M., Krishna P.T., Jagadeesh A.M. Propensity-matched analysis of association between preoperative anemia and in-hospital mortality in cardiac surgical patients undergoing valvular heart surgeries. Ann Card Anaesth. 2015;18(3):373–379. https://doi.org/10.4103/0971-9784.159808.; Hersh E.H., Sarkiss C.A., Ladner T.R., Lee N., Kothari P., Lakomkin N., Caridi J.M. Perioperative Risk Factors for Thirty-Day Morbidity and Mortality in the Resection of Extradural Thoracic Spine Tumors. World Neurosurg. 2018;120:950–956. https://doi.org/10.1016/j.wneu.2018.08.195.; Richards T., Musallam K.M., Nassif J., Ghazeeri G., Seoud M., Gurusamy K.S., Jamali F.R. Impact of Preoperative Anemia and Blood Transfusion on Postoperative Outcomes in Gynaecological Surgery. PLoS ONE. 2015;10(7):e0130861. https://doi.org/10.1371/journal.pone.0130861.; van Straten A.H., Hamad M.A., van Zundert A.J., Martens E.J., Schönberger J.P., de Wolf A.M. Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting: a comparison with the matched general population. Circulation. 2009;120(2):118–125. https://doi.org/10.1161/CIRCULATIONAHA.109.854216.; Dahlerup J.F., Eivindson M., Jacobsen B.A., Jensen N.M., Jørgensen S.P., Laursen S.B. et al. Diagnosis and treatment of unexplained anemia with iron deficiency without overt bleeding. Dan Med J. 2015;62(4):C5072. Available at: https://pubmed.ncbi.nlm.nih.gov/25872536/; Boening A., Boedeker R.H., Scheibelhut C., Rietzschel J., Roth P., Schönburg M. Anemia before coronary artery bypass surgery as additional risk factor increases the perioperative risk. Ann Thorac Surg. 2011;92(3):805–810. https://doi.org/10.1016/j.athoracsur.2011.02.076.; Leahy M.F., Hofmann A., Towler S., Trentino K.M., Burrows S.A., Swain S.G. et al. Improved outcomes and reduced costs associated with a healthsystem-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017;57(6):1347–1358. https://doi.org/10.1111/trf.14006.; Nissenson A.R., Goodnough L.T., Dubois R.W. Anemia: not just an innocent bystander? 2003;163(12):1400-4. Arch Intern Med. 2003;163(12):1100– 1404. https://doi.org/10.1001/archinte.163.12.1400.; Pfuntner A., Wier L.M., Stocks C. Most frequent procedures performed in U.S. Hospitals, 2011: Ststistical Brief 3165. In: Healthcare Cost and Utilization Project (HCUP). 2013. Available at: https://pubmed.ncbi.nlm.nih.gov/24354027/; Murphy G.J., Reeves B.C., Rogers C.A., Rizvi S.I., Culliford L., Angelini G.D. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116(22): 2544–2552. https://doi.org/10.1161/CIRCULATIONAHA.107.698977.; Shander A., Javidroozi M., Ozawa S., Hare G.M. What is really dangerous: anaemia or transfusion? Br J Anaesth. 2011;107(1 Suppl.):i41–i59. https://doi.org/10.1093/bja/aer350.; Middelburg R.A., van de Watering L.M., Briët E., van der Bom J.G. Storage time of red blood cells and mortality of transfusion recipients. Transfus Med Rev. 2013;27(1):36–43. https://doi.org/10.1016/j.tmrv.2012.06.002.; Salpeter S.R., Buckley J.S., Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med. 2014;127(2):124–131.e3. https://doi.org/10.1016/j.amjmed.2013.09.017.; Froessler B., Palm P., Weber I., Hodyl N.A., Singh R., Murphy E.M. The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial. Ann Surg. 2016;264(1):41–46. https://doi.org/10.1097/SLA. 0000000000001646.; Spahn D.R., Schoenrath F., Spahn G.H., Seifert B., Stein P., Theusinger O.M. et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet. 2019;393(10187):2201–2212. https://doi.org/10.1016/S0140- 6736(18)32555-8.; Gómez-Ramírez S., Maldonado-Ruiz M.Á., Campos-Garrigues A., Herrera A., Muñoz M. Short-term perioperative iron in major orthopedic surgery: state of the art. Vox Sang. 2019;114(1):3–16. https://doi.org/10.1111/vox.12718.; Parker M.J. Iron supplementation for anemia after hip fracture surgery: a randomized trial of 300 patients. J Bone Joint Surg Am. 2010;92(2):265– 269. https://doi.org/10.2106/JBJS.I.00883.; Shander A., Knight K., Thurer R., Adamson J., Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med. 2004;116(7A Suppl.):58S–69S. https://doi.org/10.1016/j.amjmed.2003.12.013.; Goodnough L.T., Maggio P., Hadhazy E., Shieh L., Hernandez-Boussard T., Khari P., Shah N. Restrictive blood transfusion practices are associated with improved patient outcomes. Transfusion. 2014;54(10 Pt. 2):2753– 2759. https://doi.org/10.1111/trf.12723; Muñoz M., Acheson A.G., Bisbe E., Butcher A., Gómez-Ramírez S., Khalafallah A.A. et al. An international consensus statement on the management of postoperative anaemia after major surgical procedures. Anaesthesia. 2018;73(11):1418–1431. https://doi.org/10.1111/anae.14358.; Suehiro K., Joosten A., Alexander B., Cannesson M. Continuous noninvasive hemoglobin monitoring: ready for prime time? Curr Opin Crit Care. 2015;21(3):265–270. https://doi.org/10.1097/MCC.0000000000000197.; Barker S.J., Shander A., Ramsay M.A. Continuous Noninvasive Hemoglobin Monitoring: A Measured Response to a Critical Review. Anesth Analg. 2016;122(2):565–572. https://doi.org/10.1213/ANE.0000000000000605.; Gayat E., Aulagnier J., Matthieu E., Boisson M., Fischler M. Non-invasive measurement of hemoglobin: assessment of two different point-of-care technologies. PLoS ONE. 2012;7(1):e30065. https://doi.org/10.1371/journal.pone.0030065.; Kozek-Langenecker S.A., Ahmed A.B., Afshari A., Albaladejo P., Aldecoa C., Barauskas G. et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol. 2017;34(6):332–395. https://doi.org/10.1097/EJA.0000000000000630.; American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology. 2015;122(2):241– 275. https://doi.org/10.1097/ALN.0000000000000463.; Klein A.A., Arnold P., Bingham R.M., Brohi K., Clark R., Collis R. et al. AAGBI guidelines: the use of blood components and their alternatives 2016. Anaesthesia. 2016;71(7):829–842. https://doi.org/10.1111/anae.13489.; Spahn D.R., Muñoz M., Klein A.A., Levy J.H., Zacharowski K. Patient Blood Management: Effectiveness and Future Potential. Anesthesiology. 2020;133(1):212–222. https://doi.org/10.1097/ALN.0000000000003198.; https://www.med-sovet.pro/jour/article/view/6376

الاتاحة: https://www.med-sovet.pro/jour/article/view/6376
https://doi.org/10.21518/2079-701X-2021-12-398-404

المؤلفون: A. Khashukoeva Z., A. Naumov V., A. Meshkov D., O. Rassokhina V., А. Хашукоева З., А. Наумов В., А. Мешков Д., О. Рассохина В.

المصدر: Meditsinskiy sovet = Medical Council; № 10 (2021); 140-146 ; Медицинский Совет; № 10 (2021); 140-146 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: rheumatoid arthritis, menopause, perimenopause, tocilizumab, osteoporosis, osteopenia, systemic inflammation, estrogens, hormone replacement therapy, ревматоидный артрит, менопауза, перименопауза, тоцилизумаб, остеопороз, остеопения, системное воспаление, эстрогены, заместительная гормональная терапия

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/6276/5690; Насонов Е.Л. (ред.). Российские клинические рекомендации. Ревматология. М.: ГЭОТАР-Медиа; 2017. 464 с. Режим доступа: https://www.rosmedlib.ru/book/ISBN9785970442616.html.; Барышева Ю.В., Ершова О.Б., Белосельский К.Н. Качество жизни у женщин с ревматоидным артритом и остеопорозом в постменопаузе. Остеопороз и остеопатии. 2002;(3):6-12. Режим доступа: https://cyber-leninka.ru/article/n/kachestvo-zhizni-u-zhenschin-s-revmatoidnym-artritom-i-osteoporozom-v-postmenopauze/viewer.; Carette S., Marcoux S., Gingras S. Postmenopausal Hormones and the Incidence of Rheumatoid Arthritis. J Rheumatol. 1989;16(7):911-913. Available at: https://pubmed.ncbi.nlm.nih.gov/2769663/.; Goemaere S., Ackerman C., Goethals K., De Keyser F., Van der Straeten C., Verbruggen G. et al. Onset of Symptoms of Rheumatoid Arthritis in Relation to Age, Sex and Menopausal Transition. J Rheumatol. 1990;17(12):1620-1622. Available at: https://pubmed.ncbi.nlm.nih.gov/2084234/.; Gabriel S.E. The Epidemiology of Rheumatoid Arthritis. Rheum Dis Clin North Am. 2001;27(2):269-281. https://doi.org/10.1016/s0889-857x(05)70201-5.; Ahlmen M., Svensson B., Albertsson K., Forslind K., Hafstrom I. Influence of Gender on Assessments of Disease Activity and Function in Early Rheumatoid Arthritis in Relation to Radiographic Joint Damage. Ann Rheum Dis. 2010;69(1):230-233. https://doi.org/10.1136/ard.2008.102244.; Сухих ГТ, Сметчик В.П., Юренева С.В., Ермакова Е.И., Чернуха ГЕ., Якушевская О.В. Менопауза и климактерическое состояние у женщины. Клинические рекомендации. М.: Министерство здравоохранения Российской Федерации; 2016. 45 с. Режим доступа: http://naonob.ru/media/2018/07/07/1241338634/Menopauza_i_klimaktericheskoe_sostoyanie_u_zhenshhiny.pdf.; Lleo A., Battezzati PM., Selmi C., Gershwin M.E., Podda M. Is Autoimmunity a Matter of Sex? Autoimmun Rev. 2008;7(8):626-630. https://doi.org/10.1016/j.autrev.2008.06.009.; Ostensen M., Aune B., Husby G. Effect of Pregnancy and Hormonal Changes on the Activity of Rheumatoid Arthritis. Scand J Rheumatol. 1983;12(2):69-72. https://doi.org/10.3109/03009748309102886.; Barrett L., Henzi PS., Weingrill T., Lycett J.L., Hill R.A. Female Baboons Do Not Raise the Stakes But They Give As Good As They Get. Anim Behav. 2000;59(4):763-770. https://doi.org/10.1006/anbe.1999.1361.; Kanik K.S., Wilder R.L. Hormonal Alterations in Rheumatoid Arthritis, Including the Effects of Pregnancy. Rheum Dis Clin North Am. 2000;26(4):805-823. https://doi.org/10.1016/s0889-857x(05)70170-8.; Ostensen M. Sex Hormones and Pregnancy in Rheumatoid Arthritis and Systemic Lupus Erythematosus. Ann N YAcad Sci. 1999;876:131-143. https://doi.org/10.1111/j.1749-6632.1999.tb07630.x.; Pikwer M., Bergstrom U., Nilsson J.A., Jacobsson L., Turesson C. Early Menopause Is an Independent Predictor of Rheumatoid Arthritis. Ann Rheum Dis. 2012;71(3):378-381. https://doi.org/10.1136/ard.2011.200059.; Ali E.T., Alsharrad A.K., Shari F.H. 17p-Estradiol Hormone and Interleukin 1-Beta Change Related to Menopause in the Women with Rheumatoid Arthritis. Asian J Pharm. 2019;13(2):110-118. Available at: https://www.researchgate.net/publication/332849001.; Farage M.A., Miller K.W., Maibach H.I. Effects of Menopause on Autoimmune Diseases. Expert Rev Obstet Gynecol. 2012;(7):557-571. https://doi.org/10.1586/eog.12.63.; Kuiper S., van Gestel A.M., Swinkels H.L., de Boo T.M., da Silva J.A., van Riel P.L. Influence of Sex, Age, and Menopausal State on the Course of Early Rheumatoid Arthritis. J Rheumatol. 2001;(28):1809-1816. Available at: https://pubmed.ncbi.nlm.nih.gov/11508583/.; Camacho E.M., Verstappen S., Chipping J., Symmons D. Learned Helplessness Predicts Functional Disability, Pain and Fatigue in Patients with Recent-Onset Inflammatory Polyarthritis. Rheumatology. 2013;(52):1233-1238. https://doi.org/10.1093/rheumatology/kes434.; Islander U., Jochems C., Lagerquist M.K., Forsblad-d'Elia H., Carlsten H. Estrogens in Rheumatoid Arthritis; the Immune System and Bone. Mol Cell Endocrinol. 2011;335(1):14-29. https://doi.org/10.1016/j.mce.2010.05.018.; Eun Y., Jeon K.H., Han K., Kim D., Lee J., Lee D. Menopausal Factors and Risk of Seropositive Rheumatoid Arthritis in Postmenopausal Women: A Nationwide Cohort Study of 1.36 Million Women. Sci Rep. 2020;10(1):20793. https://doi.org/10.1038/s41598-020-77841-1.; Ильина Л.М. Артриты в климактерии (влияние заместительной гормональной терапии). Гинекология. 2003;(2):79-81. Режим доступа: http//elib.fesmu.ru/elib/Article.aspx?id=94390.; Beydoun H.A., El-Amin R., McNeal M., Perry C., Archer D.F. Reproductive History and Postmenopausal Rheumatoid Arthritis among Women 60 Years or Older: Third National Health and Nutrition Examination Survey. Menopause. 2013;(20):930-935. https://doi.org/10.1097/GME.0b013e3182a14372.; Kokkonen H., Soderstrom I., Rocklov J., Hallmans G., Lejon K., Rantapaa Dahlqvist S. Up-Regulation of Cytokines and Chemokines Predates the Onset of Rheumatoid Arthritis. Arthritis Rheum. 2010;62(2):383-391. https://doi.org/10.1002/art.27186.; Chen D.Y. Hsieh T.Y., Chen Y.M., Hsieh C.W., Lan J.L., Lin FJ. Proinflammatory Cytokine Profiles of Patients with Elderly-Onset Rheumatoid Arthritis: A Comparison with Younger-Onset Disease. Gerontology. 2009;55(3):250-258. https://doi.org/10.1159/000164393.; Насонов Е.Л., Лила А.М. Ингибиция интерлейкина 6 при иммуновоспалительных ревматических заболеваниях: достижения, перспективы и надежды. Научно-практическая ревматология. 2017;55(6):590-599. https://doi.org/10.14412/1995-4484-2017-590-599.; Singh J.A., Hossain A., Tanjong Ghogomu E., Mudano A.S., Maxwell LJ., Buchbinder R. et al. Biologics or Tofacitinib for People with Rheumatoid Arthritis Unsuccessfully Treated with Biologics: A Systematic Review and Network Meta-Analysis. Cochrane Database Syst Rev. 2017;3:CD012591. https://doi.org/10.1002/14651858.CD012591.; Tarp S., Furst D.E., Dossing A., 0stergaard M., Lorenzen T., Hansen M.S., Singh J.A. et al. Defining the Optimal Biological Monotherapy in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomised Trials. Semin Arthritis Rheum. 2017;46(6):699-708. https://doi.org/10.1016/j.semarthrit.2016.09.003.; McKendry R., Smolen J.S., Churchill M., Tocilizumab Treatment Results in Rapid Improvements in the Signs and Symptoms of Moderate-to-Severe Rheumatoid Arthritis in Four Patient Populations with Different Prior Therapy Exposure. J Rheumatol. 2009;36. Available at: https://www.researchgate.net/publication/278353202_Tocilizumab_Treatment_Results_in_Rapid_Improvements_in_the_Signs_and_Symptoms_of_Moderate-to-Severe_Rheumatoid_Arthritis_in_Four_Patient_Populations_with_Different_ Prior_Therapy_Exposure.; Beaulieu A.D., McKay J.D., Pavelka K., Davies C., John A., Smolen J.S. Treatment with the Humanized Anti-Interleukin-6 Receptor Antibody Tocliizumab Results in Rapid Improvements in the Signs and Symptoms of Rheumatoid Arthritis: Results from a Pooled Analysis of Clinical Trial Data from OPTION and TOWARD. Ann Rheum Dis. 2008;67(Suppl II):195.; Forsblad-d'Elia H., Bengtsson K., Kristensen L.E., Jacobsson L.T. Drug Adherence, Response and Predictors Thereof for Tocilizumab in Patients with Rheumatoid Arthritis: Results from the Swedish Biologics Register. Rheumatology (Oxford). 2015;54(7):1186-1193. https://doi.org/10.1093/rheumatology/keu455.; Yamamoto K., Goto H., Hirao K., Nakajima A., Origasa H., Nakasone A. et al. SAT0194. Long Term Safety for Tocilizumab in Real-World Setting; 3 Year Follow-Up Postmarketing Surveillance of 5573 Patients with Rheumatoid Arthritis in Japan. Ann Rheum Dis. 2015;74:725-726. http://doi.org/10.1136/annrheumdis-2015-eular.1569.; Chen Y.M., Chen H.H., Huang W.N., Liao T.L., Chen J.P., Chao W.C. et al. Tocilizumab Potentially Prevents Bone Loss in Patients with Anti-citrullinated Protein Antibody-Positive Rheumatoid Arthritis. PLoS One. 2017;12(11):e0188454. https://doi.org/10.1371/journal.pone.0188454.; Briot K., Schaeverbeke T., Etchepare F., Gaudin P., Perdriger A., Vray M. et al. Positive Effects of Tocilizumab On Bone Remodeling in Patients with Rheumatoid Arthritis. 2012ACR/ARHPAnnual Meeting. Available at: https://acrabstracts.org/abstract/positive-effects-of-tocilizumab-on-bone-remodeling-in-patients-with-rheumatoid-arthritis/.; Koster MJ., Matteson E.L., Warrington KJ. Recent Advances in the Clinical Management of Giant Cell Arteritis and Takayasu Arteritis. Curr Opin Rheumatol. 2016;28(3):211-217. https://doi.org/10.1097/BOR.0000000000000265.; Toussirot Ё., Regent A., Devauchelle-Pensec V, Saraux A., Puechal X. Interleukin-6: A Promising Target for the Treatment of Polymyalgia Rheumatica or Giant Cell Arteritis? RMD Open. 2016;2(2):e000305. https://doi.org/10.1136/rmdopen-2016-000305.; Kume K., Amano K., Yamada S., Kanazawa T., Ohta H., Hatta K. et al. The Effect of Tocilizumab on Bone Mineral Density in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis. Rheumatology (Oxford). 2014;53(5):900-903. https://doi.org/10.1093/rheumatology/ket468.; Shin A., Park E.H., Dong Y.H., Ha YJ., Lee YJ., Lee E.B. et al. Comparative Risk of Osteoporotic Fracture among Patients with Rheumatoid Arthritis Receiving TNF Inhibitors versus Other Biologics: A Cohort Study. Osteoporos Int. 2020;31(11):2131-2139. https://doi.org/10.1007/s00198-020-05488-9.; Suzuki T., Nakamura Y, Kato H. Effects of Denosumab on Bone Metabolism and Bone Mineral Density with Anti-TNF Inhibitors, Tocilizumab, or Abatacept in Osteoporosis with Rheumatoid Arthritis Ther Clin Risk Manag. 2018;(14):453-459. https://doi.org/10.2147ACRM.S156350.; Pers Y.M., Schaub R., Constant E., Lambert J., Godfrin-Valnet M., Fortunet C. et al. Efficacy and Safety of Tocilizumab in Elderly Patients with Rheumatoid Arthritis. Joint Bone Spine. 2015;82(1):25-30. https://doi.org/10.1016/j.jbspin.2014.07.010.; https://www.med-sovet.pro/jour/article/view/6276

الاتاحة: https://www.med-sovet.pro/jour/article/view/6276
https://doi.org/10.21518/2079-701X-2021-10-140-146

المؤلفون: A. Naumov V., T. Prokofieva V., O. Polunina S., L. Saroyants V., E. Polunina A., А. Наумов В., Т. Прокофьева В., О. Полунина С., Л. Сароянц В., Е. Полунина А.

المساهمون: нет

المصدر: Medical Herald of the South of Russia; Том 11, № 3 (2020); 40-47 ; Медицинский вестник Юга России; Том 11, № 3 (2020); 40-47 ; 2618-7876 ; 2219-8075 ; 10.21886/2219-8075-2020-11-3

مصطلحات موضوعية: chronic obstructive pulmonary disease, myocardial infarction, comorbid pathology, cytokines, interleukins, хроническая обструктивная болезнь легких, инфаркт миокарда, коморбидная патология, цитокины, интерлейкины

وصف الملف: application/pdf

Relation: https://www.medicalherald.ru/jour/article/view/1092/772; Divo M., Cote C., de Torres J.P., Casanova C., Marin J.M. et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. // Am J Respir Crit Care Med. – 2012. - V. 186. - P. 155–161. https://doi.org/10.1164/rccm.201201-0034OC; Vanfleteren L.E., Spruit M.A., Groenen M, Gaffron S., van Empel V.P. et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. // Am J Respir Crit Care Med. – 2013. - V. 187. - P. 728–735. https://doi.org/10.1164/rccm.201209-1665OC; Barnett K., Mercer S.W., Norbury M., Watt G.G., Wyke S. et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. // Lancet. – 2012. - V. 380. - P. 37–43. https://doi.org/10.1016/S0140-6736(12)60240-2; Andell P., Koul S., Martinsson A., Sundström J., Jernberg T. et al. Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction. // Open Heart. – 2014. - 1:e000002. https://doi.org/10.1136/openhrt-2013-000002; Brekke P.H., Omland T., Smith P., Soyseth V. Underdiagnoses of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalized for COPD exacerbation. // Respir Med. - 2008. - V. 102 - P. 1243–1247. https://doi.org/10.1016/j.rmed.2008.04.010; Morgan A.D., Zakeri R., Quint J.K. Defining the relationship between COPD and CVD: what are the implications for clinical practice? // Ther. Respir. Dis. - 2018. - V. 12. - P. 11–16. https://doi.org/10.1177/1753465817750524; Kunisaki K.M., Dransfield M.T., Anderson J.A., Brook R.D., Calverley P.M. et al. Exacerbations of chronic obstructive pulmonary disease and cardiac events: a cohort analysis. // Am J Respir Crit Care Med. – 2018. - V. 198. P. 51–557. https://doi.org/10.1164/rccm.201711-2239OC; Donaldson G.C., Hurst J.R., Smith C.J., Hubbard R.B., Wedzicha J.A. Increased risk of myocardial infarction and stroke following exacerbation of COPD. // Chest. – 2010. - V. 137. - P. 1091–1097. https://doi.org/10.1378/chest.09-2029; Linden F., Domschke G., Erbel C., Akhavanpoor M., Katus H.A., Gleissner C.A. Inflammatory therapeutic targets in coronary atherosclerosis-from molecular biology to clinical application. // Front Physiol. – 2014. - V. 5. - P. 455. https://doi.org/10.3389/fphys.2014.00455; Van Eeden S., Leipsic J., Paul Man S.F., Sin D.D. The relationship between lung inflammation and cardiovascular disease. // Am J Respir Crit Care Med. – 2012. - V. 186. - P. 11–16. Corpus ID: 53508730; Roversi S., Roversi P., Spadafora G., Rossi R., Fabbri L.M. Coronary artery disease concomitant with chronic obstructive pulmonary disease. // Eur J Clin Invest. – 2014. - V. 44. - P. 93–102. https://doi.org/10.1111/eci.12181; Dinarello C.A. Interleukin 1b and interleukin 18 as mediators of inflammation and the aging process. // Am.J.Clin. Nutr. - 2006. 83. - V. 2. - P. 4447-455. https://doi.org/10.1093/ajcn/83.2.447s; Chen B.B., Li Z.H., Gao S. Circulating miR-146a/b correlates with inflammatory cytokines in COPD and could predict the risk of acute exacerbation COPD. // Medicine (Baltimore). – 2018. - V. 97 (7). - P. e9820. https://doi.org/10.1097/MD.0000000000009820; Min X., Lu M., Tu S., Wang X., Pang S. et al. Serum cytokine profile in relation to the severity of coronary artery disease // Biomed Research international. - 2017. - 9 p. https://doi.org/10.1155/2017/4013685; Simon A.D., Yazdani S., Wang W., Schwartz A., Rabbani L.E. Elevated plasma levels of interleukin-2 and soluble IL-2 receptor in ischemic heart disease // Clin Cardiol. – 2001. - V. 24. - № 3. – P. 253-256. https://doi.org/10.1002/clc.4960240315; Han S.F., Li X.Y., Liu K.W., Wang L., Cui R. et al. Imbalance of T helper 1 cells/T helper 2 cells accelerated T-cell-mediated endothelium injury in patients with acute coronary syndromes. // Zhonghua Xin Xue Guan Bing Za Zhi. – 2008. - V. 36. - P. 1070–1073. Corpus ID: 8661528; Barczyk A., Pierzchała W., Kon O.M., Cosio B., Adcock I.M. et al. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. // J Allergy Clin Immunol. - 2006. - V. 117. - № 11. – P. 1484-1492. https://doi.org/10.1016/j.jaci.2006.02.013; Luc G., Bard J.M., Juhan-Vague I., Ferrieres J., Evans A. et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: The PRIME study. // Arterioscler Thromb Vasc Biol. – 2003. V. 23. – P. 1255-1261. https://doi.org/10.1161/01.atv.0000079512.66448.1d; Шаленкова М.А., Михайлова З.Д., Манюкова Э.Т., Басалгина Т.А., Шишкина А.П. Уровни содержания интерлейкинов и мелатонина у больных острым коронарным синдромом // Медицинская иммунология. - 2014. - Т. 16. - № 5.- С. 473-480. https://doi.org/10.15789/1563-0625-2017-2-191-196; Виткина Т.И., Денисенко Ю.К., Сидлецкая К.А. Изменение экспрессии рецептора к IL-6 на поверхности иммунокомпетентных клеток при прогрессировании хронической обструктивной болезни легких // Медицинская иммунология. – 2017. - Т. 19. - № 2. - С. 191-196. https://doi.org/10.15789/1563-0625-2017-2-191-196.; Passoni F., Morelli B., Seveso G., Lazzati L., Beria G. et al. Comparaitive short-term prognostic value of hemostatic and inflammatoery markers in patients with non-ST elevation acute coronary syndrome. // Ital. Heart J. – 2002. - V. 3. - P. 28-35. Corpus ID: 45088993; Поликутина О.М., Слепынина Ю.С., Баздырев Е.Д., Каретникова В.Н., Барбараш О.Л. Исходы инфаркта миокарда с подъемом сегмента ST у пациентов с хронической обструктивной болезнью легких в Кемеровской области. // Российский Кардиологический Журнал. – 2014. Т. 7 (111). – С. 91-97. https://doi.org/10.15829/1560-4071-2014-7-91-97; Ozdemir O., Gundogdu F., Karakelleoglu S., Sevimli S., Pirim I. et al. Comparison of serum levels of inflammatory markers and allelic variant of interleukin-6 in patients with acute coronary syndrome and stable angina pectoris. // Coron Artery Dis. - 2008. - V. 19. - P. 15–19. https://doi.org/10.1097/mca.0b013e3282f27bf7; Kilic T. Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome. // Heart. – 2006. - V. 92. - P. 1041–1046. https://doi.org/10.1136/hrt.2005.080382; Dizdarević-Hudić L., Kušljugić Z., Baraković F., Brkić S., Sabitović D., et al. Correlation between interleukin 6 and interleukin 10 in acute myocardial infarction. // Bosn J Basic Med Sci. – 2009. - V. 9(4). - P. 301–306. https://doi.org/10.17305/bjbms.2009.2784; Hilde E.G., Lawien Al Ali, Iwan C.C. van der Horst, Remco A.J.S. et al. Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction. // Clinical Research in Cardiology. – 2018. – P. 612-621. https://doi.org/10.1007/s00392-018-1387-z; Bennermoa M., Held C., Green F., Strandberg L.-E., Ericsson C.-G. et al. Prognostic value of plasma interleukin-6 concentrations and the −174 G > C and −572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. // Atherosclerosis May. – 2004. V. 174 (1). – P. 157–163. https://doi.org/10.1016/j.atherosclerosis.2004.01.019; Аляви А.Л., Низомов А.А., Касимова Г.М. Клинико-диагностическое значение активации цитокинов и возможности коррекции нарушений у больных острым коронарным синдромом с подъемом сегмента ST. // Тезисы Российского национального конгресса кардиологов. – 2012. - №0024. - С. 43-44.; https://www.medicalherald.ru/jour/article/view/1092

الاتاحة: https://www.medicalherald.ru/jour/article/view/1092
https://doi.org/10.21886/2219-8075-2020-11-3-40-47

المؤلفون: Наумов, В. Л.

المصدر: Current Problems of State and Law; No 35 (2007): Actual problems of state and law; 373-376 ; Актуальные проблемы государства и права; № 35 (2007): Актуальные проблемы государства и права; 373-376 ; Актуальні проблеми держави і права; № 35 (2007): Актуальні проблеми держави і права; 373-376 ; 2309-818X

وصف الملف: application/pdf

Relation: http://apdp.onua.edu.ua/index.php/apdp/article/view/2645/2514; http://apdp.onua.edu.ua/index.php/apdp/article/view/2645

الاتاحة: http://apdp.onua.edu.ua/index.php/apdp/article/view/2645
https://doi.org/10.32837/apdp.v0i35.2645

المؤلفون: A. Naumov V., V. Moroz I., N. Khovasova O., T. Manevich M., M. Balaeva M.-B., D. Demenok V., O. Tkacheva N., А. Наумов В., В. Мороз И., Н. Ховасова О., Т. Маневич М., М. Балаева М.-Б., Д. Деменок В., О. Ткачева Н.

المصدر: Meditsinskiy sovet = Medical Council; № 12 (2019); 106-114 ; Медицинский Совет; № 12 (2019); 106-114 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2019-12

مصطلحات موضوعية: pain, chronic pain, geriatric syndrome, dinopenia, sarcopenia, physical functioning of patients, osteoarthritis, back pain, musculoskeletal diseases, chondroitin sulphate (Chondroguard®), glucosamine sulphate (Sustaguard® Artro), боль, хроническая боль, гериатрический синдром, динопения, саркопения, физическое функционирование больных, остеоартрит, боль в спине, скелетно-мышечные заболевания, хондроитина сульфат (Хондрогард®), глюкозамина сульфат (Сустагард® Артро)

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/3141/3057; Macfarlane GJ., Barnish M.S., Jones G.T. Persons with chronic widespread pain experience excess mortality: longitudinal results from UK Biobank and meta-analysis. Annats of the Rheumatic Diseases. 2017;76:1815-1822.; Patel K.V., Guralnik J.M., Dansie EJ., Turk D.C. Prevalence and impact of pain among older adults in the United States: findings from the 2011 national health and aging trends study. Pain. 2013;154:2649-57.; Docking R.E., Fleming J., Brayne C., Zhao J., Macfarlane GJ., Jones G.T. Epidemiology of back pain in older adults: prevalence and risk factors for back pain onset. Rheumatology (Oxford). 2011;50:1645-53.; Yu H.Y., Tang F.I., Kuo BI.T., Yu S. Prevalence, interference, and risk factors for chronic pain among Taiwanese community older people. Pain Manag Nurs. 2006;7:2-11.; Jakobsson U. The epidemiology of chronic pain in a general population: results of a survey in southern Sweden. ScandJ Rheumatol. 2010;39:421-429.; Larsson C., Hansson, E., Sundquist K., & Jakobsson U. Chronic pain in older adults: prevalence, incidence, and risk factors. Scandinavian Journal of Rheumatology. 2016;46(4):317-325.; Wilkie R., Tajar A., McBeth J. The onset of widespread musculoskeletal pain is associated with a decrease in healthy ageing in older people: a population-based prospective study. PLoS One. 2013;8:59858.; Leung Y Y., Teo S.L., Chua M.B., Raman P. Liu C. Chan A. Living arrangements, social networks and onset or progression of pain among older adults in Singapore. Geriatr Gerontol Int. 2016;16:693-700.; Van Hecke O. Torrance N. Smith B.H. Chronic pain epidemiology and its clinical relevance. Br J Anaest. 2013;111:13-18.; Shega J.W., Dale W., Andrew M., Paice J., Rockwood K., Weiner D.K. Persistent pain and frailty: a case for homeostenosis. J Am Geriatr Soc. 2012;60:113-117.; Dziechciaz M., Balicka-Adamik L., Filip R. The problem of pain in old age. Ann Agric Environ Med. 2013;20:35-38; Lints-Martindale A.C., Hadjistavropoulos T., Lix L.M., Thorpe L. A comparative investigation of observational pain assessment tools for older adults with dementia. Clin J Pain. 2012;28:226-237; Critchley M. The neurology of old age. Lancet. 1931;217:1331-1337.; Rosenberg I.H. Sarcopenia: Origins and Clinical Relevance. The Journal of Nutrition. 1997;127(5):990-991.; Ундрицов В.М., Ундрицов И.М., Серова Л.Д. Возрастные изменения мышечной системы. Руководство по геронтологии. Под ред. акад. Шабалина В.Н. 2005:486-499.; Kamimoto L.A., Easton A.N., Maurice E., Husten C.G., Macera C.A. Surveillance for Five Health Risks Among Older Adults. United States, 1993-1997. CDC MMWR Surveillance Summaries, Dec 17, 1999;48(SS08):89-130.; Cruz-Jentoft AJ., Landi F., Schneider S.M., Zuniga C., Arai H., Boirie Y., et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):748-759.; Zhang X., Zhang W., Wang C., Tao W., Dou O., Yang Y. Sarcopenia as a predictor of hospitalization among older people: a systematic review and meta-analysis. BMC Geriatr. 2018;18(1): 188.; Bianchi L., Abete P, Bellelli G., Bo M., Cherubini A., Corica F. et al. Prevalence and clinical correlates of sarcopenia, identified according to the EWGSOP definition and diagnostic algorithm, in hospitalized older people: the GLISTEN study. J. Gerontol. 2017;72(11):1575-158.; Malmstrom T.K., Miller D.K., Simonsick E.M. et al. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7:28-36.; Sakai Y., Matsui H., Ito S., et aL. Sarcopenia in elderly patients with chronic low back pain. Osteoporos Sarcopenia. 2017;3(4):195-200.; De Ceuninck F., Fradin A., Pastoureau P Bearing arms against osteoarthritis and sarcopenia: when cartilage and skeletal muscle find common interest in talking together. Drug Discov Today. 2013.; Karasik D., Kiel D.P. Evidence for pleiotropic factors in genetics of the musculoskeletal system. Bone. 2010;46:1226-1237.; Burr D.B. Muscle strength, bone mass, and age-related bone loss. J Bone Miner Res. 1997;12:1547-1551.; Brandt K.D., Dieppe P., Radin E.L. Etiopathogenesis of osteoarthritis. Rheum Dis Clin North Am. 2008;34:531-559.; Arokoski M.H., Arokoski J.P., Haara M., Kankaanpaa M., Vesterinen M., Niemitukia L.H. Hip muscle strength and muscle cross sectional area in men with and without hip osteoarthritis. J Rheumatol. 2002;29:2185-95.; Toda Y., Segal N., Toda T., Kato A., Toda F. A., decline in lower extremity lean body mass per body weight is characteristic of women with early phase osteoarthritis of the knee. J Rheumatol. 2000;27:2449-2454.; Zhai G., Blizzard L., Srikanth V., Ding C., Cooley H., Cicuttini F. Correlates of knee pain in older adults: Tasmanian older adult Cohort study. Arthritis Rheum. 2006;55:264-271.; O’Reilly S.C., Jones A., Muir K.R., Doherty M. Quadriceps weakness in knee osteoarthritis: the effect on pain and disability. Ann Rheum Dis. 1998;57:588-594.; Nevitt M.C., Cummings S.R., Kidd S., Black D. Risk factors for recurrent nonsyncopal falls: a prospective study. J Am Med Assoc. 1989;261:2663-2668.; Scott D., Blizzard L., Fell J., Jones G. A prospective study of the associations between selfreported pain, radiographic osteoarthritis and sarcopenia in community-dwelling older adults. Arthritis Care Res. 2011.; Phillips PS., Haas R.H., Bannykh S., Hathaway S., Gray N.L., Kimura BJ. Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med. 2002;137:581-585.; Scott D., Blizzard L., Fell J., Jones G. Statin therapy, muscle function and falls risk in communitydwelling older adults. QJM. 2009;102:625-633.; Krishnan G.M., Thompson P.D. The effects of statins on skeletal muscle strength and exercise performance. Curr Opin Lipidol. 2010;21:324-328.; Hernandez Morante JJ., Gomez Martinez C., Morillas-Ruiz J.M. Dietary Factors Associated with Frailty in Old Adults: A Review of Nutritional Interventions to Prevent Frailty Development. Nutrients. 2019;11(1):102.; Gaksch M., Jorde R., Grimnes G., Joakimsen R., Schirmer H., Wilsgaard T. Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS ONE. 2017;12(2):e0170791.; Pusceddu I., Farrell C., Di Pierro A. The role of telomeres and vitamin D in cellular aging 51. and age-related diseases. Clinical Chemistry and Laboratory Medicine (CCLM). 2015;53(11):1661- 1678.; Scimeca M., Centofanti F., Celi M. Vitamin D. Receptor in Muscle Atrophy of Elderly Patients: A Key Element of Osteoporosis-Sarcopenia Connection. Aging Dis. 2018;9(6):952-964. 52.; Wu Z., Malihi Z., Stewart A.W., Lawes C.M., Scragg R. The association between vitamin D concentration and pain: a systematic review and metaanalysis. Public Health Nutr. 2018;21:1-16.; Wu Z., Malihi Z., Stewart A.W., Lawes C.M., Scragg R. Effect of Vitamin D Supplementation on Pain: A Systematic Review and Metaanalysis. Pain Physician. 2016;19(7):415-427.; Cruz-Jentoft AJ. et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing. 2018.; White D.K., Neogi T., Nevitt M.C., Peloquin C.E., Zhu Y., Boudreau R.M. et al. Trajectories of gait speed predict mortality in well-functioning older adults: the Health, Aging and Body Composition study. The Jornals of Gerontology 54. Series A: Biological Sciences and Medical Science. 2012;68(4):456-464.; Мокрышева Н.П, Крупинова Ю.А., Володичева В.Л., Мирная С.С., Мельниченко ПА. Саркопения глазами эндокринолога. Ожирение и метаболизм, 2018;15(3):21-27.; Yarasheski K.E. Exercise, aging, and muscle protein me- tabolism. J. Gerontol. A Biol. Sci. Med. Sci. 2003;58(10):918-922.; Beaudart C. Outcomes of the IOF-ESCEO sarcopenia working groups. WCO-IOF-ESCEO. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; 2018 April 19-22, Krakow, Poland. Springer, 2018:77-78.; Saggini R., Carmignano S.M., Cosenza L. et al. Sarcopenia in Chronic Illness and Rehabilitative Approaches, Frailty and Sarcopenia. IntechOpen.; Arsenis N.C., You T., Ogawa E.F., Tinsley G.M., Zuo L. Physical activity and telomere length: Impact of aging and potential mechanisms of action. Oncotarge. 2017;8(27):45008-45019.; Hirschfeld H.P., Kinsella R., Duque G. Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos. Int. 2017;28(10):2781-2790.; Conzade R., Grill E., Bischoff-Ferrari, H.A. et al. Vitamin D in Relation to Incident Sarcopenia and Changes in Muscle Parameters Among Older Adults: The KORA-Age Study. Calcif Tissue Int. 2019.; Verlaan S., Maier A.B., Bauer J.M., Bautmans I., Brandt K., Donini L.M. et al. Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopen-ic older adults - The PROVIDE study.T Clinical Nutrition. 2018;37(2):551-557.; Bruyere, Olivier et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Seminars in Arthritis and Rheumatism. 44, 3:253-26.; Rovati L.C., Girolami F., Persiani S. Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties. Ther Adv Musculoskelet Dis. 2012;4:167-180.; Громова ОА., Торшин И.Ю., Лила А.М., Шостак Н.А., Рудаков К.В. Молекулярные механизмы миопротективного действия хондроити-на сульфата и глюкозамина сульфата при сар-копении. Неврология, нейропсихиатрия, психосоматика. 2019;11(1):117-124.; Davis A.K., Carlson S.S. Proteoglycans are present in the transverse tubule system of skeletal muscle. Matrix Biol. 1995;14(8):607-621.; Stabler T.V., Huang Z., Montell E., Verges J., Kraus V.B. Chondroitin sulphate inhibits NF-kB activity induced by interaction of pathogenic and damage associated molecules. Osteoarthritis and Cartilage. 2017, 25, 1.; Le N.H., Kim C.S., Park T., et al. Quercetin protects against obesity-induced skeletal muscle inflammation and atrophy. Mediators Inflamm. 2014;2014:834294.; Fioravanti A., Collodel G. In Vitro Effects of Chondroitin Sulfate. Advances in Pharmacology. 2006; 53:449-465.; Takeuchi S., Nakano S.I., Nakamura K., Ozoe A., Chien P, Yoshihara H. еt al. Roles of chondroitin sulfate proteoglycan 4 in fibrogenic/adipogenic differentiation in skeletal muscle tissues. Experimental Cell Research. 2016;347(2):367-377.; Hutchison CJ., Yasin R. Developmental changes in sulphation of chondroitin sulphate proteoglycan during myogenesis of human muscle cultures. Dev Biol. 1986;115(1):78-83.; Taşkesen A., Ataoglu B., Ozer M., Demirkale i., Turanli S. Glucosamine-chondroitin sulphate accelerates tendon-to-bone healing in rabbits. Eklem Hastalik Cerrahisi. 2015;26(2):77-83.; Petersen S.G., Beyer N., Hansen M., et al. Nonsteroidal anti-inflammatory drug or glucosamine reduced pain and improved muscle strength with resistance training in a randomized controlled trial of knee osteoarthritis patients. Arch Phys Med Rehabil. 2011; 92(8):1185-93.; Reginster J.L., Bruyere O., Cooper C. Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms. Ann Rheum Dis. 2017.; https://www.med-sovet.pro/jour/article/view/3141

الاتاحة: https://www.med-sovet.pro/jour/article/view/3141
https://doi.org/10.21518/2079-701X-2019-12-106-114

المؤلفون: Насковец, Михаил Трофимович, Жлобич, Павел Николаевич, Афонин, П. В., Наумов, В. В.

مصطلحات موضوعية: дорожные конструкции, геопрослойки «Тератекс», прочностные параметры дорожных конструкций, упрочняющие геопрослойки, конструкции дорожных одежд, модели дорожных конструкций

وصف الملف: application/pdf

Relation: Исследование прочностных параметров дорожных конструкций с геопрослойками «Тератекс» / М. Т. Насковец [и др.] // Технологическая независимость и конкурентоспособность Союзного государства, стран СНГ, ЕАЭС и ШОС : сборник статей VI Международной научно-технической конференции "Минские научные чтения - 2023", Минск, 6-8 декабря 2023 г. : в 3 т. - Минск : БГТУ, 2023. - Т. 2. - С. 297-301.; https://elib.belstu.by/handle/123456789/61725; 630*383+630*37

الاتاحة: https://elib.belstu.by/handle/123456789/61725